Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2019 2
2020 4
2021 6
2022 10
2023 5
2024 4
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cremona m (114 results)?
Toxic Occupational Exposures and Membranous Nephropathy.
Cremoni M, Agbekodo S, Teisseyre M, Zorzi K, Brglez V, Benzaken S, Esnault V, Planchard JH, Seitz-Polski B. Cremoni M, et al. Clin J Am Soc Nephrol. 2022 Nov;17(11):1609-1619. doi: 10.2215/CJN.02930322. Epub 2022 Oct 25. Clin J Am Soc Nephrol. 2022. PMID: 36283759 Free PMC article.
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.
Teisseyre M, Allinovi M, Audard V, Cremoni M, Belvederi G, Karamé A, Accinno M, Duquesne J, Sharma V, Fernandez C, Zorzi K, El Maï M, Brglez V, Benzaken S, Esnault VLM, Vultaggio A, Kohli HS, Ramachandran R, Cirami CL, Seitz-Polski B. Teisseyre M, et al. Among authors: cremoni m. Kidney Int Rep. 2024 Dec 17;10(3):753-761. doi: 10.1016/j.ekir.2024.12.012. eCollection 2025 Mar. Kidney Int Rep. 2024. PMID: 40225374 Free PMC article.
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.
Allinovi M, Teisseyre M, Accinno M, Finocchi C, Esnault VLM, Cremoni M, Mazzierli T, Lazzarini D, Casiraghi MA, Fernandez C, Zorzi K, Brglez V, Cosmi L, Matucci A, Caroti L, Antognoli G, Cirami CL, Vultaggio A, Seitz-Polski B. Allinovi M, et al. Among authors: cremoni m. Kidney Int Rep. 2025 May 6;10(8):2621-2629. doi: 10.1016/j.ekir.2025.04.059. eCollection 2025 Aug. Kidney Int Rep. 2025. PMID: 40814630 Free PMC article.
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation.
Cremoni M, Teisseyre M, Thaunat O, Fernandez C, Payre C, Moutou A, Zarif H, Brglez V, Albano L, Moal V, Mourad G, Morelon E, Hurault de Ligny B, Zaoui P, Rondeau E, Ouali N, Ronco P, Moulin B, Braun-Parvez L, Durrbach A, Heng AE, Grimbert P, Ducloux D, Blancho G, Merville P, Choukroun G, Le Meur Y, Vigneau C, Mariat C, Rostaing L, Subra JF, Taupin JL, Lambeau G, Esnault V, Sicard A, Seitz-Polski B. Cremoni M, et al. Kidney Int Rep. 2024 Sep 23;9(12):3427-3438. doi: 10.1016/j.ekir.2024.09.012. eCollection 2024 Dec. Kidney Int Rep. 2024. PMID: 39698349 Free PMC article.
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.
Destere A, Teisseyre M, Merino D, Cremoni M, Gérard AO, Crepin T, Jourde-Chiche N, Graça D, Zorzi K, Fernandez C, Brglez V, Benzaken S, Esnault VLM, Benito S, Drici MD, Seitz-Polski B. Destere A, et al. Among authors: cremoni m. Kidney Int Rep. 2023 Nov 3;9(1):134-144. doi: 10.1016/j.ekir.2023.10.023. eCollection 2024 Jan. Kidney Int Rep. 2023. PMID: 38312797 Free PMC article.
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.
Teisseyre M, Destere A, Cremoni M, Boyer-Suavet S, Karamé A, Corlu L, Duneau G, Poirier P, Lefevre S, Zorzi K, Fernandez C, Brglez V, Benzaken S, Favre G, Drici MD, Esnault VLM, Benito S, Seitz-Polski B. Teisseyre M, et al. Among authors: cremoni m. Clin Kidney J. 2025 Apr 16;18(5):sfaf113. doi: 10.1093/ckj/sfaf113. eCollection 2025 May. Clin Kidney J. 2025. PMID: 40322676 Free PMC article. No abstract available.
Rituximab bioavailability in primary membranous nephropathy.
Boyer-Suavet S, Andreani M, Cremoni M, Brglez V, Benzaken S, Bernard G, Nachman P, Esnault V, Seitz-Polski B. Boyer-Suavet S, et al. Among authors: cremoni m. Nephrol Dial Transplant. 2019 Aug 1;34(8):1423-1425. doi: 10.1093/ndt/gfz041. Nephrol Dial Transplant. 2019. PMID: 30929012 No abstract available.
35 results